Study | Control/‘Deeper’ sedation | Intervention/‘Lighter’ sedation |
Balzer et al17 | Patients had >85% RASS scores ≤−3 First RASS −5 (−5 to −4) Time to reach first RASS >−3: 79 (52−141) hours | First RASS: −4 (−5 to −1), p<0.001 Time to reach first RASS >−3: 11 (5–20) hours, p=0.001 |
Bugedo et al18 | Midazolam: 0.03 (0.01–0.06) mg/kg/hour Fentanyl: 0.6 (0.1–1.4) μg/kg/hour Proportion: SAS 1–2: 55%; SAS 3–4: 37% | Midazolam: 0.01 (0–0.03) mg/kg/hour, p<0.001 Fentanyl: 1.5 (0.8–2.4) μg/kg/hour, p<0.001 Proportion: SAS 1–2: 44%; SAS 3–4: 49%, p=0.001 |
Burry et al41 | Midazolam: 97.0±200.8 mg/patient/day Fentanyl: 1.9±3.5 mg/patient/day | Midazolam: 64.7±245.8 mg/patient/day, p<0.0001 Fentanyl: 1.1±2.0 mg/patient/day, p<0.0001 |
Dale et al19 | Hourly benzodiazepine dose: 0.23±0.018 mg Total benzodiazepine dose: 49.2±156.5 mg 24 hours weighted average RASS: −1.30±0.026 | Hourly benzodiazepine dose: 0.15±0.011 mg, p<0.01 Total benzodiazepine dose: 17.2±53.6, p<0.01 24 hours weighted average RASS: −0.99±0.023, p<0.01 |
Faust et al20 | RASS (median): −2.57 ((−3.23 to −1.40) % RASS scores −3 to −5 in first 24 hours: 46.8%±46.9% | RASS (median): −1.25 (−2.3 to −0.40), p=0.001 % RASS scores −3 to −5 in first 24 hours: 27.3%±37.3%, p=0.006 |
Guttormson21 | Classed as ‘minimally arousable’ based on Sedation Intensity Score | Classed as ‘easily arousable’ based on Sedation Intensity Score |
Khan et al22 | RASS scores—weekdays: median—4 RASS scores—weekends: median—5 | RASS—weekdays: increased by 0.88, p<0.0001 RASS—weekends: increased by 1.20, p<0.0001 |
Mehta et al23 † | Midazolam: 102±326 mg/patient/day Fentanyl: 1780±4135 µg/patient/day | Midazolam: 102±326 mg/patient/day, p=0.04 Fentanyl: 1070±2066 µg/patient/day, p<0.001 |
Nassar Junior, Park M24 | SAS scores: 3.2 (2.6–3.7) Midazolam: 45 (0.201) mg Fentanyl: 1500 (520–4215) mg | SAS scores: 3.6 (3.4–4.0), p=0.035 Midazolam: 0 (0.0–0.05) mg, p<0.001 Fentanyl: 300 (100–1520) mg, p=0.004 |
Olsen et al25 | Midazolam mg/kg/hour (day 2–28): 0.000187 (0–0.003410) Propofol mg/kg/hour (day 1–2): 0.84 (0.29–1.2); (day 3–28): 0.0064 (0–0.034) Mean RASS: day 1: −2.3; day 7: −1.8 | Midazolam mg/kg/hour (day 2–28): 0 (0–0.000005); NS Propofol mg/kg/hour (day 1–2): 0.22 (0–0.054); difference: −0.62 (−0.72; −0.53); (day 3–28): 0 (0–0.013); difference: −0.0063 (−0.874; −0.0037) Mean RASS: day 1: −1.3; day 7: −0.8 |
Quenot et al26 | Midazolam: 92±59 mg/patient/day Propofol: 2900±1400 mg/patient/day | Midazolam: 44±31 mg/patient/day, p=0.001 Propofol: 1840±750 mg/patient/day, p=0.01 |
Ren et al31 | Sufentanil: 0.030±0.007 mg/kg/hour Midazolam: 0.029±0.007 mg/kg/hour | Sufentanil: 0.018±0.009 mg/kg/hour, p<0.0001 Midazolam: 0.017±0.009 mg/kg/hour, p<0.0001 |
Samuelson et al27 | Target MAAS: 1–2 Actual MAAS: median 1.25 (1.0) | Target MAAS: 3–4 Actual MAAS: median 3.0 (0.0) |
Sen et al32 | Total benzodiazepine dose: 450±701 mg | Total benzodiazepine dose: 74±159 mg, p<0.01 |
Shehabi et al28 | Dexmedetomidine: 20.58 (20.58–20.58) µg Midazolam: 0.3 (0.23–0.76) mg Propofol: 33.55 (13.54–77.07) mg RASS assessments −2 to +1: 38% | Dexmedetomidine: 36.55 (16.38–13.23) µg, p<0.0001 Midazolam: 0.06 (0.02–1) mg, p=0.036 Propofol: 9.89 (2.41–22.51) mg, p=0.046 RASS assessments −2 to +1: 66%, p=0.01 |
Shehabi et al33 | RASS −3 to −5 at 48 hours | RASS lighter than −3 to −5 at 48 hours |
Strøm et al42 | Propofol: 1.40 (0.52–2.04) mg/kg/hour Midazolam: 0.01 (0–0.04) mg/kg/hour | Propofol: 0 (0–1.26) mg/kg/hour, p=0.013 Midazolam: 0 (0–0) mg/kg/hour, p=0.003 |
Strøm et al29 | Propofol: 0.77 (0.15–1.65) mg/kg/hour Midazolam: 0.003 (0–0.024) mg/kg/hour | Propofol: 0 (0–0.52) mg/kg/hour, p=0.0001 Midazolam: 0 (0–0) mg/kg/hour, p<0.0001 |
Treggiari et al30 | Target Ramsay sedation score 3–4 Daily median Ramsay range: 3 (2–4.5) to 4 (3–5) Daily midazolam range: 24.2±45.1 to 95.3±124.5 mg | Target Ramsay sedation score 1–2 Daily median Ramsay range: 1 (1–2) to 3 (1–3) Daily midazolam range: 3.0±5.0 to 11.7±23.2 mg |
*It was not possible to create two categories of ‘deeper’ or ‘lighter’ sedation in seven studies.34–39
†‘Deeper’ sedation group was the intervention (daily interruption of sedation) group.
MAAS, Motor Activity Assessment Scale; RASS, Richmond Agitation Sedation Scale; SAS, Riker Sedation Agitation Scale.